Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Deb Mills

Dr Deb Mills

Travel Medicine Update for General Practice

Dr Katherine Spira

Dr Katherine Spira

Choosing the Right Migraine Preventative

Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm

Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm

Expert Panel – Atherosclerosis and Blood Lipid Management

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism – When & Who to Refer

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024